Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia

被引:182
作者
Rosón, B
Carratalà, J
Fernández-Sabé, N
Tubau, F
Manresa, F
Gudiol, F
机构
[1] Univ Barcelona, Hosp Univ Bellvitge, Infect Dis Serv, Barcelona 08907, Spain
[2] Univ Barcelona, Hosp Univ Bellvitge, Microbiol Serv, Barcelona 08907, Spain
[3] Univ Barcelona, Hosp Univ Bellvitge, Resp Serv, Barcelona 08907, Spain
关键词
D O I
10.1001/archinte.164.5.502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Early failure is a matter of great concern in the treatment of community-acquired pneumonia. However, information on its causes and risk factors is lacking. Methods: Observational analysis of a prospective series of 1383 nonimmunosuppressed hospitalized adults with community-acquired pneumonia. Early failure was defined as lack of response or worsening of clinical or radiologic status at 48 to 72 hours requiring changes in antibiotic therapy or invasive procedure's. Concordance of antimicrobial therapy was examined for cases with an etiologic diagnosis. Results: At 48 to 72 hours, 238 patients (18%) remained febrile, but most of them responded without further changes in antibiotic therapy. Eighty-one patients (6%) had early failure. The main causes of early failure were progressive pneumonia (n=54), pleural empyema (n=18), lack of response (n=13), and uncontrolled sepsis (n=9). Independent factors associated with early failure were older age (>65 years) (odds ratio [OR], 0.35), multilobar pneumonia (OR, 1.81), Pneumonia Severity Index score greater than 90 (OR, 2.75), Legionella pneumonia (OR, 2.71), gram-negative pneumonia (OR, 4.34), and discordant antimicrobial therapy (OR, 2.51). Compared with treatment responders, early failures had significantly higher rates of complications (58% vs 24%) and overall mortality (27% vs 4%) (P<.001 for both). Conclusions: Early failure is infrequent but is associated with high morbidity and mortality rates. Its detection and management require careful clinical assessment. Most cases occur because of inadequate host-pathogen responses. Discordant therapy is a less frequent cause of failure, which may be preventable by rational application of the current antibiotic guidelines.
引用
收藏
页码:502 / 508
页数:7
相关论文
共 50 条
  • [21] Prognostic factors and outcome of community-acquired pneumonia in hospitalized adult patients
    Saldías, F
    Mardónez, JM
    Marchesse, M
    Viviani, P
    Farías, G
    Díaz, A
    REVISTA MEDICA DE CHILE, 2002, 130 (12) : 1373 - 1382
  • [22] Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia
    Villafuerte, David
    Aliberti, Stefano
    Soni, Nilam J.
    Faverio, Paola
    Marcos, Pedro J.
    Wunderink, Richard G.
    Rodriguez, Alejandro
    Sibila, Oriol
    Sanz, Francisco
    Martin-Loeches, Ignacio
    Menzella, Francesco
    Reyes, Luis F.
    Jankovic, Mateja
    Spielmanns, Marc
    Restrepo, Marcos I.
    RESPIROLOGY, 2020, 25 (05) : 543 - 551
  • [23] Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia
    Goldstein, Lee Hilary
    Gabin, Ahmad
    Fawaz, Abdallah
    Freedberg, Nahum Adam
    Schwartz, Naama
    Elias, Mazen
    Saliba, Walid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (10) : 1042 - 1048
  • [24] Factors associated with mortality in younger and older (≥75 years) hospitalized patients with community-acquired pneumonia
    Aydin, Mehtap
    Saylan, Bengu
    Iscanli, Insa Gul Ekiz
    ANNALS OF SAUDI MEDICINE, 2022, 42 (01) : 45 - 51
  • [25] Causes of death for patients with community-acquired pneumonia
    Strålin, K
    Holmberg, H
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (21) : 2491 - 2492
  • [26] The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia
    Tasbakan, Mehmet Sezai
    Bacakoglu, Feza
    Basoglu, Ozen Kacmaz
    Gurgun, Alev
    Basarik, Burcu
    Tuncel, Senay Citim
    Sayiner, Abdullah
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2011, 59 (04): : 348 - 354
  • [27] Factors associated with unknown aetiology in patients with community-acquired pneumonia
    Ewig, S
    Torres, A
    Marcos, MA
    Angrill, J
    Rañó, A
    de Roux, A
    Mensa, J
    Martínez, JA
    de la Bellacasa, JP
    Bauer, T
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) : 1254 - 1262
  • [28] Utilization of CT in patients hospitalized with community-acquired pneumonia
    Hofmann, LV
    Beall, DP
    Scott, WW
    Kuhlman, JE
    Moore, RD
    Mundy, LM
    RADIOLOGY, 1996, 201 : 549 - 549
  • [29] Epidemiology of Community-Acquired Pneumonia in Hospitalized Pediatric Patients
    Regueras Santos, L.
    Iglesias Blazquez, C.
    Ledesma Benitez, I.
    Roson Varas, M.
    Lapena Lopez De Armentia, S.
    Gutierrez Garcia, P.
    BOLETIN DE PEDIATRIA, 2008, 48 (203): : 37 - 45
  • [30] Prediction of Mortality in Community-Acquired Pneumonia in Hospitalized Patients
    Musonda, Patrick
    Sankaran, Prasanna
    Subramanian, Deepak N.
    Smith, Alexandra C.
    Prentice, Philippa
    Tariq, Syed M.
    Kamath, Ajay V.
    Myint, Phyo K.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 342 (06) : 489 - 493